Contribution of Abdominal Visceral Obesity and Insulin Resistance to the Cardiovascular Risk Profile of Postmenopausal Women
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The aim of this study was to determine the respective contribution of abdominal visceral adipose tissue (AT) accumulation and insulin resistance (IR) to the determination of a comprehensive cardiovascular metabolic risk profile in 108 postmenopausal women not receiving hormone therapy. Insulin sensitivity (M/I) was determined by a hyperinsulinemic-euglycemic clamp, and visceral AT area was measured by computed tomography. Median values of visceral AT (133.9 cm2) and insulin sensitivity (0.010189 mg · kg−1 · min−1 · pmol−1) were used to form four subgroups: 1) low visceral AT-low IR (n = 35), 2) low visceral AT-high IR (n = 19), 3) high visceral AT-low IR (n = 19), and 4) high visceral AT-high IR (n = 35). Women with isolated IR (low visceral AT and high IR) were characterized by significantly higher fasting and 2-h glycemia and higher fibrinogen, triglyceride, and VLDL-apolipoprotein (apo)B concentrations than women with low visceral AT and low IR (P < 0.05). The plasma lipid-lipoprotein profile and inflammatory markers were not significantly different between women with high visceral AT and low IR and women with low visceral AT and low IR. Women with high visceral AT and high IR had higher fasting and 2-h glycemia, triglyceride, and VLDL-apoB levels; lower apoAI and HDL2 cholesterol levels; as well as higher C-reactive protein and interleukin-6 concentrations than women with low visceral AT and low IR (P < 0.05). In addition, 15 of the 35 women (42.9%) in the high visceral AT and high IR group were newly diagnosed with type 2 diabetes, whereas no women were diagnosed with type 2 diabetes in the group of women with low visceral AT and low IR. These results show that although the presence of high IR in its isolated form is associated with some metabolic alterations, it is the combination of both high visceral AT and high IR that is the most detrimental for the metabolic health in postmenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 1×
“These alterations in fatty acid metabolism may represent a mechanism by which IR could be linked to hypertriglyceridemia (46).”
BackgroundEffect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Goodpaster, B. H., Leland Thaete, F., Simoneau, J.-A., & Kelley, D. E. (1997) · Diabetes · doi:10.2337/diacare.46.10.1579 · Cited by 1,012
Carr, D. B., Utzschneider, K. M., Hull, R. L., Kodama, K., Retzlaff, B. M., Brunzell, J. D., Shofer, J. B., Fish, B. E., Knopp, R. H., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2087 · Cited by 993
Cnop, M., Landchild, M. J., Vidal, J., Havel, P. J., Knowles, N. G., Carr, D. R., Wang, F., Hull, R. L., Boyko, E. J., Retzlaff, B. M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1005 · Cited by 432
Couillard, C., Després, J.-P., Lamarche, B., Bergeron, J., Gagnon, J., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.092137 · Cited by 331
Self-citationNieves, D. J., Cnop, M., Retzlaff, B., Walden, C. E., Brunzell, J. D., Knopp, R. H., & Kahn, S. E. (2003) · Diabetes · doi:10.2337/diabetes.52.1.172 · Cited by 281 · cited 3×
“These results support data from a recent study in which it was observed that subjects with both increased abdominal AT levels and IR were characterized by a more deteriorated lipid-lipoprotein profile compared with subjects with low abdominal AT levels and low IR (29).”
BackgroundResultInfluentialMcLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., & Reaven, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.032 · Cited by 268 · cited 1×
“associated with clustering of CVD risk factors in nondiabetic subjects as well as in subjects with type 2 diabetes (12).”
BackgroundUusitupa, M., Lindi, V., Louheranta, A., Salopuro, T., Lindström, J., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes · doi:10.2337/diabetes.52.10.2532 · Cited by 196 · cited 1×
“However, weight still remains a relevant clinical target when appropriate because it has been shown to be associated with improved insulin sensitivity (43).”
BackgroundAnderson, J. W., Konz, E. C., & Jenkins, D. J. A. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718955 · Cited by 122 · cited 1×
“These results are relevant from a clinical point of view since they emphasize the importance of intervention strategies aiming at improving insulin sensitivity rather than focusing solely on a reduction in body weight, which is often difficult to achieve and maintain (42).”
Background
Cited by
Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
Meigs, J. B., Wilson, P. W. F., Fox, C. S., Vasan, R. S., Nathan, D. M., Sullivan, L. M., & D’Agostino, R. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0594 · Cited by 1,062
Fain, J. N. (2006) · Vitamins & Hormones · doi:10.1016/s0083-6729(06)74018-3 · Cited by 679
Sniderman, A. D., Bhopal, R., Prabhakaran, D., Sarrafzadegan, N., & Tchernof, A. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dyl245 · Cited by 343
Maurovich-Horvat, P., Massaro, J., Fox, C. S., Moselewski, F., O'Donnell, C. J., & Hoffmann, U. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803454 · Cited by 298
Metabolic Syndrome and Menopause
(2015) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2015.07.001 · Cited by 215
Metadata
- Authors
- Piché, M.-E., Weisnagel, S. J., Corneau, L., Nadeau, A., Bergeron, J., & Lemieux, S.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-03-01
- Volume
- 54
- Issue
- 3
- Pages
- 770-777
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2132258820
- Cited by
- 88
- References
- 10
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contribution of Abdominal Visceral Obesity and Insulin Resistance to the Cardiovascular Risk Profile of Postmenopausal Women. https://app.cochat.ai/papers/10.2337/diabetes.54.3.770
- The paper
- Piché, M.-E., Weisnagel, S. J., Corneau, L., Nadeau, A., Bergeron, J., & Lemieux, S. (2005). Contribution of Abdominal Visceral Obesity and Insulin Resistance to the Cardiovascular Risk Profile of Postmenopausal Women. Diabetes. https://doi.org/10.2337/diabetes.54.3.770
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.